SCHEMBL5207244

SCHEMBL5207244

COc1ccccc1Oc1cnc(N)nc1NC1CCC(O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.45
INSR P06213 1/20 0.45
LCK P06239 1/20 0.45
PDGFRB P09619 1/20 0.45
PDGFRA P16234 1/20 0.45
TRPM8 Q7Z2W7 2/20 0.44
MERTK Q12866 6/20 0.43
TYRO3 Q06418 5/20 0.43
AXL P30530 3/20 0.43
FLT3 P36888 3/20 0.43
GAS6 Q14393 3/20 0.43
MAPK8 P45983 2/20 0.42
MAPK9 P45984 2/20 0.42
MAPK10 P53779 1/20 0.42
CDK1 P06493 3/20 0.41
CDK4 P11802 2/20 0.41
CCND1 P24385 2/20 0.41
CDK2 P24941 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5207250 1.00 EGFR (0.45) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL1376658 0.89 SYK (0.42) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL1376660 0.89 SYK (0.42) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL5207562 0.89 BTK (0.43) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL5207566 0.89 BTK (0.43) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL5203804 0.86 MAPK14 (0.47) MERTKTYRO3AXLFLT3GAS6
SCHEMBL5203808 0.86 MAPK14 (0.47) MERTKTYRO3AXLFLT3GAS6
SCHEMBL1379026 0.85 MAPT (0.44) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL1379021 0.85 MAPT (0.44) EGFRINSRLCKPDGFRBPDGFRA
SCHEMBL1379044 0.83 MAPK14 (0.39) EGFRINSRLCKPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed